疏血通联合依达拉奉治疗脑梗死的疗效分析  

Efficacy analysis of Shuxuetong combined with edaravone in the treatment of cerebral infarction

作　　者：姜伟 JIANG Wei(Kaiyuan Central Hospital,Kaiyuan 112300,China)

机构地区：[1]开原市中心医院,112300

出　　处：《中国现代药物应用》2021年第19期205-207,共3页Chinese Journal of Modern Drug Application

摘　　要：目的分析疏血通联合依达拉奉治疗脑梗死的疗效。方法50例脑梗死患者,均给予依达拉奉联合疏血通治疗。分析患者治疗前后美国国立卫生研究院卒中量表评分、Barthel指数、治疗效果。结果治疗后,患者的美国国立卫生研究院卒中量表评分(7.56±1.21)分低于治疗前的(21.15±2.21)分,Barthel指数(82.21±2.40)分高于治疗前的(37.67±1.21)分,差异有统计学意义(P<0.05)。患者治疗总有效率为96.00%(48/50)。结论依达拉奉联合疏血通治疗脑梗死的临床效果确切,可有效减轻患者的神经功能缺损程度,改善其生活能力,值得推广。Objective To analyze the efficacy of Shuxuetong combined with edaravone in the treatment of cerebral infarction.Methods There were 50 patients with cerebral infarction,and all were treated with edaravone combined with Shuxuetong.The National Institutes of Health stroke scale score and Barthel index score before and after treatment,and therapeutic effects of patients were compared.Results After treatment,the National Institutes of Health stroke scale score(7.56±1.21)points of patients was lower than(21.15±2.21)points before treatment,and the Barthel index(82.21±2.40)points was higher than the score before treatment(37.67±1.21)points.All the differences were statistically significant(P<0.05).The total effective rate of treatment for patients was 96.00%(48/50).Conclusion Combination of Shuxuetong and edaravone has definite clinical effect in the treatment of cerebral infarction,and it can effectively reduce the degree of neurological deficits and their living ability,which is worthy of promotion.

关 键 词：疏血通 依达拉奉 脑梗死 疗效 

分 类 号：R743.33[医药卫生—神经病学与精神病学]